Candida vulvovaginitis epidemiology and demographics

Jump to navigation Jump to search

Candida vulvovaginitis Microchapters


Patient Information


Historical Perspective




Differentiating Candidiasis from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


History and Symptoms

Physical Examination

Laboratory Findings

X Ray


Other Imagining Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Candida vulvovaginitis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Candida vulvovaginitis epidemiology and demographics

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Candida vulvovaginitis epidemiology and demographics

CDC on Candida vulvovaginitis epidemiology and demographics

Candida vulvovaginitis epidemiology and demographics in the news

Blogs on Candida vulvovaginitis epidemiology and demographics

Directions to Hospitals Treating Candidiasis

Risk calculators and risk factors for Candida vulvovaginitis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2], Aravind Kuchkuntla, M.B.B.S[3]


Candida vulvovaginitis is not a reportable disease and epidemiological studies on the prevalence of the disease are hard to perform.

Epidemiology and Demographics


  • Incidence of Candida vulvovaginitis is higher in pregnant women.[4][5]
  • Women in reproductive age group are prone for Candida vulvovaginits and at least one episode is reported in 70 to 75% in this population group.[6]
  • 40 to 50% of patients with a prior yeast infection have multiple episodes of yeast infection.[4]
  • Among the adult population 5 to 8% women have more than four episodes of infection.[7]
  • In 20% asymptomatic healthy adolescent women, Candida species can be isolated from the vagina.[8]


Candida vulvovaginitis is more prevalent among African American women than white American women.[7]


  1. Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, Reed BD, Summers PR (1998). "Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations". Am. J. Obstet. Gynecol. 178 (2): 203–11. PMID 9500475.
  2. Sobel JD (2007). "Vulvovaginal candidosis". Lancet. 369 (9577): 1961–71. doi:10.1016/S0140-6736(07)60917-9. PMID 17560449.
  3. Allsworth JE, Peipert JF (2007). "Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data". Obstet Gynecol. 109 (1): 114–20. doi:10.1097/01.AOG.0000247627.84791.91. PMID 17197596.
  4. 4.0 4.1 Hurley R, De Louvois J (1979). "Candida vaginitis". Postgrad Med J. 55 (647): 645–7. PMC 2425644. PMID 523355.
  5. García Heredia M, García SD, Copolillo EF, Cora Eliseth M, Barata AD, Vay CA; et al. (2006). "[Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents]". Rev Argent Microbiol. 38 (1): 9–12. PMID 16784126.
  6. Zuckerman, Andrea; Romano, Mary (2016). "Clinical Recommendation: Vulvovaginitis". Journal of Pediatric and AdolescentGynecology. 29 (6): 673–679. doi:10.1016/j.jpag.2016.08.002. ISSN 1083-3188.
  7. 7.0 7.1 Foxman B, Marsh JV, Gillespie B, Sobel JD (1998). "Frequency and response to vaginal symptoms among white and African American women: results of a random digit dialing survey". J Womens Health. 7 (9): 1167–74. PMID 9861594.
  8. Barousse, M M (2004). "Vaginal yeast colonisation, prevalence of vaginitis, and associated local immunity in adolescents". Sexually Transmitted Infections. 80 (1): 48–53. doi:10.1136/sti.2002.003855. ISSN 1368-4973.

Template:WH Template:WS